Gallbladder and bile duct cancer, known as cholangiocarcinoma, is a rare cancer that forms in the bile ducts or gallbladder. These ducts carry bile from the liver to the small intestine to aid digestion. Cholangiocarcinoma can develop within the liver (intrahepatic) or outside it (extrahepatic).
Location plays a key role in determining treatment and prognosis for each type.
Symptoms are often subtle, including jaundice, weight loss, and abdominal pain. Risk factors include liver disease, bile duct stones, and chronic inflammation. Early detection is key for treatment, which may involve surgery, chemotherapy, or radiation therapy.
Symptoms of cholangiocarcinoma are often subtle and can go unnoticed in its early stages, making it difficult to detect. Common signs include jaundice (yellowing of the skin and eyes), unexplained weight loss, abdominal pain, and dark urine. Risk factors include chronic liver disease, primary sclerosing cholangitis (a disease that affects the bile ducts), bile duct stones, and certain genetic conditions. Additionally, long-term inflammation of the bile ducts can increase the risk of developing this cancer.
Diagnosis often involves imaging tests like CT scans, MRIs, or ultrasounds, and may require biopsies to confirm the presence of cancerous cells. Cholangiocarcinoma is typically treated through surgery, especially if detected early. However, in more advanced cases, treatments like chemotherapy, radiation therapy, or targeted therapy may be employed to manage the disease.
Given the rarity and complexity of gallbladder and bile duct cancer, early diagnosis and treatment are crucial for improving survival rates. Awareness of symptoms and risk factors can help in early detection, leading to better outcomes.
We are available 7 days a week and have specific clinic hours with all doctors on staff. Outside of normal clinic hours you can receive an on call Doctor or Nurse at your nearby hospital if needed.
